No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
YEMEN – Yemen’s Ministry of Public Health and Population (MOPHP), the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO) have joined forces to reduce the scourge of…
Read More
USA — The U.S. Centers for Disease Control and Prevention (CDC) has announced their endorsement of Pfizer’s respiratory syncytial virus (RSV) vaccine for expectant mothers in their third trimester. This…
Read More
SOUTH AFRICA — In an alliance to bolster global healthcare, the Department of Science and Innovation (DSI) and Germany’s KfW Development Bank have inked a historic financing agreement. This pivotal…
Read More
GERMANY — Germany’s pioneering biopharmaceutical company, BioNTech, has embarked on a transformative journey in the realm of infectious disease prevention, partnering with the Coalition for Epidemic Preparedness Innovations (CEPI). This…
Read More
USA — Moderna, the Massachusetts-based pioneer in mRNA technology, has entered into a substantial agreement worth up to US$1.8 billion with Immatics, a specialist in T-cell receptor (TCR) therapies. This…
Read More
NIGERIA — The National Primary Health Care Development Agency (NPHCDA) in Nigeria has unveiled a groundbreaking initiative known as the Zero-Dose Learning Hub (ZDLH) to target children who have not…
Read More
RWANDA — In a concerted effort to safeguard the health of its youngest citizens, the Rwandan Ministry of Health has embarked on an expansive campaign to administer the crucial second…
Read More
GHANA — The International Vaccine Institute (IVI), EuBiologics, and DEK Vaccines Limited (DEK) have solidified their collaboration by signing a memorandum of understanding (MOU) aimed at amplifying the production of…
Read More
NORWAY— In a bid to bolster global readiness against emerging infectious diseases, the Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) have renewed their multi-year collaboration.…
Read More
SOUTH AFRICA — An analysis of South Africa’s COVID-19 vaccine contracts has shed light on pricing disparities and risk assumptions made by pharmaceutical companies. According to the Health Justice Initiative…
Read More